YAP1 and lung cancer: Combination therapy with VP and gefitinib inhibited YAP1, p-ERK and ps75-bad in lung cancer cells, and suppressed PC9 mir-630 knockout lung cancer xenografts in nude mice (Wu et al., 2018).